Tag: 上海品茶网DFT

As Trump looks overseas for drug pricing ideas, one expert says France has some useful approaches

first_img GET STARTED As the U.S. grapples with rising costs for prescription medicines, the Trump administration has floated a proposal that would have Medicare use a so-called International Pricing Index as a benchmark to pay for certain drugs. Although still being crafted, the idea has, once again, focused attention on the different prices paid in the U.S. and other countries. So Suffolk University professor Marc Rodwin, who specializes in health law, has begun studying payment systems elsewhere and recently looked at France, where retail drug spending declined between 2008 and 2017, compared with rising spending in the U.S. We spoke with him about the different approaches taken by the two countries and what lessons can be learned. This is an edited version of our conversation.Pharmalot: What prompted this and why start with France? A pharmacy in Paris. STEPHANE DE SAKUTIN/AFP/Getty Images What is it? Pharmalot [email protected] Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+. First 30 days free. GET STARTED As Trump looks overseas for drug pricing ideas, one expert says France has some useful approaches Ed Silverman STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.center_img Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. What’s included? About the Author Reprints Tags BostonDonald Trumpdrug developmentdrug pricingMedicareSTAT+ Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. Log In | Learn More @Pharmalot By Ed Silverman Dec. 3, 2019 Reprintslast_img read more